Related Experiment Video
Updated: Jun 14, 2025

Technical Aspects of the Mouse Aortocaval Fistula
Published on: July 11, 2013
The Effect of Arteriovenous Fistula Creation on GFR Decline
Beyza Doğan1, Fatih Ergül1, Mikail Dağ1
1Department of Nephrology, University of Health Sciences Konya City Hospital, Turkey.
Insights
Arteriovenous fistula (AVF) creation in chronic kidney disease (CKD) patients significantly slows estimated glomerular filtration rate (eGFR) decline. This stabilization suggests improved adherence to treatment and diet following AVF placement in end-stage kidney disease (ESKD) patients.
Area of Science:
- Nephrology
- Vascular Surgery
Background:
- Chronic kidney disease (CKD) is a major public health concern impacting patient quality of life.
- Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines suggest discussing renal replacement therapy for CKD stage 4.
- Arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis.
Purpose of the Study:
- To assess changes in kidney function post-arteriovenous fistula (AVF) creation in end-stage kidney disease (ESKD) patients.
- To evaluate the impact of AVF on the progression of kidney disease.
Main Methods:
- Retrospective analysis of 17 CKD patients undergoing AVF creation.
- Review of laboratory and medical records from 6 months pre- to 6 months post-AVF creation.
- Monitoring of estimated glomerular filtration rate (eGFR) at 1, 3, and 6 months post-AVF.
Main Results:
- The study cohort had a mean age of 62.4 years, with common comorbidities including diabetes (58.8%) and hypertension (29.4%).
- A significant decline in eGFR was observed before AVF placement.
- Kidney function, measured by eGFR, stabilized in the 6 months following AVF creation.
Conclusions:
- AVF creation in CKD patients significantly reduces the rate of eGFR decline.
- This stabilization may result from increased patient awareness and improved adherence to dietary and treatment regimens.
- AVF placement appears to positively influence kidney function trajectory in ESKD patients.
Purpose:
Chronic kidney disease (CKD) poses a significant public health challenge, severely affecting patients' quality of life. The Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines recommend discussing renal replacement therapy options when patients reach CKD stage 4. Arteriovenous fistula (AVF) creation is considered the gold standard for vascular access in hemodialysis. This retrospective study aims to evaluate whether any changes in kidney function occur during the follow-up period after AVF creation in patients with end-stage kidney disease (ESKD).
Methods:
We analyzed data from 60 CKD patients who underwent AVF creation and were monitored in our nephrology outpatient clinics. Seventeen patients who consistently attended follow-up visits were included for detailed analysis. We performed a retrospective review of laboratory and medical records from 6 months before and 6 months following AVF creation.
Results:
The cohort comprised 41.2% males, with a mean age of 62.4 years. The predominant underlying conditions were diabetes mellitus (58.8%), hypertension (29.4%), and polycystic kidney disease (11.8%). Statistical analysis of laboratory values before and after AVF creation (at 1, 3, and 6 months) revealed a significant decline in estimated glomerular filtration rate (eGFR) before AVF placement, followed by stabilization in the subsequent 6 months.
Conclusion:
The rate of eGFR decline was significantly reduced in CKD patients with AVF. This may be attributed to increased awareness of impending hemodialysis, leading to better dietary adherence and treatment compliance.
Related Concept Videos
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
Renal Drug Excretion: Glomerular Filtration
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...

